Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−20.54 M USD
2.38 M USD
15.86 M
About Upstream Bio, Inc.
Sector
Industry
CEO
E. Rand Sutherland
Website
Headquarters
Waltham
Founded
2021
FIGI
BBG017Y2X923
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of UPB is 16.21 USD — it has decreased by −2.41% in the past 24 hours. Watch Upstream Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Upstream Bio, Inc. stocks are traded under the ticker UPB.
UPB stock has fallen by −20.73% compared to the previous week, the month change is a −27.80% fall, over the last year Upstream Bio, Inc. has showed a −24.60% decrease.
We've gathered analysts' opinions on Upstream Bio, Inc. future price: according to them, UPB price has a max estimate of 75.00 USD and a min estimate of 38.00 USD. Watch UPB chart and read a more detailed Upstream Bio, Inc. stock forecast: see what analysts think of Upstream Bio, Inc. and suggest that you do with its stocks.
UPB stock is 9.96% volatile and has beta coefficient of 2.28. Track Upstream Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Upstream Bio, Inc. there?
Today Upstream Bio, Inc. has the market capitalization of 868.80 M, it has decreased by −8.78% over the last week.
Yes, you can track Upstream Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Upstream Bio, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
UPB earnings for the last quarter are −6.96 USD per share, whereas the estimation was −6.93 USD resulting in a −0.41% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Upstream Bio, Inc. earnings.
Upstream Bio, Inc. revenue for the last quarter amounts to 607.00 K USD, despite the estimated figure of 453.50 K USD. In the next quarter, revenue is expected to reach 397.25 K USD.
No, UPB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 35.00 employees. See our rating of the largest employees — is Upstream Bio, Inc. on this list?
Like other stocks, UPB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Upstream Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.